Literature DB >> 199118

Synthesis of prostaglandins by psoriatic skin.

V Kassis, K Weismann, H Heiligstädt, J Sondergaard.   

Abstract

The biosynthesis of prostaglandins (PG) in biopsies from 9 patients with psoriasis was studied. The involved as well as the uninvolved psoriatic skin showed a statistically significant decrease of the ability to synthesize PG's. In PGE1-equivalents the concentration (mean +/- S.E.M.) was 4.41 +/- 0.48 ng/g wet weight in the psoriatic lesion, 5.41 +/- 0.64 ng/g wet weight in uninvolved psoriatic skin in the presence of exogenous arachidonic acid in the incubation medium as compared with 9.02 +/- 1.59 in normal human skin. When the skin was incubated without excess of exogenous precursor acid the activity formed was similarly significantly lower in psoriatic skin as compared with normal skin. A disturbed balance between E and F PG synthesis was not demonstrated, which might have accounted for the postulated altered intracellular ratio of cyclic AMP to cyclic GMP in psoriatic skin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199118     DOI: 10.1007/bf00561448

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  12 in total

1.  PROSTAGLANDINS AND RELATED FACTORS: XIX. THIN-LAYER CHROMATOGRAPHY OF PROSTAGLANDINS.

Authors:  K GREEN; B SAMUELSSON
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

2.  Epidermal synthesis of prostaglandins and their effect on levels of cyclic adenosine 3', 5'monophosphate.

Authors:  K Aso; D G Deneau; L Krulig; D I Wilkinson; E M Farber
Journal:  J Invest Dermatol       Date:  1975-05       Impact factor: 8.551

3.  Pathogenesis of Woronoff ring in psoriasis.

Authors:  N S Penneys; V Ziboh; P Simon; J Lord
Journal:  Arch Dermatol       Date:  1976-07

4.  Pharmacologic agents released in ultraviolet inflammation studied by continuous skin pefusion.

Authors:  M W Greaves; J Sondergaard
Journal:  J Invest Dermatol       Date:  1970-05       Impact factor: 8.551

5.  Evaluation of smooth muscle bioassays for prostaglandins E 1 and F 1 alpha.

Authors:  J R Weeks; J R Schultz; W E Brown
Journal:  J Appl Physiol       Date:  1968-12       Impact factor: 3.531

6.  Pharmacological studies in inflammation due to exposure to ultraviolet radiation.

Authors:  J Sondergaard; M W Greaves
Journal:  J Pathol       Date:  1970-06       Impact factor: 7.996

7.  Reduced epidermal cyclic AMP accumulation following prostaglandin stimulation: Its possible role in the pathophysiology of psoriasis.

Authors:  K Aso; E K Orenberg; E M Farber
Journal:  J Invest Dermatol       Date:  1975-10       Impact factor: 8.551

8.  Biosynthesis of prostaglandins in human allergic contact dermatitis.

Authors:  H P Jøorgensen; J Søondergaard
Journal:  Arch Dermatol Res       Date:  1976-12-15       Impact factor: 3.017

9.  Recovery of prostaglandins in human cutaneous inflammation.

Authors:  M W Greaves; J Sondergaard; W McDonald-Gibson
Journal:  Br Med J       Date:  1971-05-01

10.  Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.

Authors:  S Hammarström; M Hamberg; B Samuelsson; E A Duell; M Stawiski; J J Voorhees
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

View more
  3 in total

1.  Influence of intercellular agents on proliferation and gene activity of cultured human skin epithelium cells (NCTC 2544).

Authors:  G Reimer; M Mentzer; K Gottschalk; A Neufahrt
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

2.  Heat-separation of normal human skin for epidermal and dermal prostaglandin analysis.

Authors:  V Kassis; J Søndergaard
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 3.  Current knowledge of the implication of lipid mediators in psoriasis.

Authors:  Mélissa Simard; Sophie Morin; Zainab Ridha; Roxane Pouliot
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.